Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes have?
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes has 1,951 citations in the OpenAlex counts ScholarIQ stores.
When was Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes published?
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes has 2021 year in the ScholarIQ index.
What is the open-access status of Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes?
Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes has green oa status in the ScholarIQ index.
What is the DOI of Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes?
The DOI for Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes is on the source record.
What is the PMID of Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes?
The PMID for Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes is on the source record.
What is the OpenAlex record for Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes?
The OpenAlex for Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes is on the source record.